Back to Search

NASSER ALTORKI, MD

MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician

NPI: 1700973898IndividualAccepts Medicare

Specialties, Licenses & Credentials

Surgery Physician

Surgery

Code: 208600000X

172895(NY)
Thoracic Surgery (Cardiothoracic Vascular Surgery) PhysicianPrimary

Thoracic Surgery (Cardiothoracic Vascular Surgery)

Code: 208G00000X

172895(NY)

CMS Specialties

PrimaryTHORACIC SURGERY

Education

OTHER

Class of 1977

Research & Publications (20)

Invited commentary.
PMID 19324128·Ann Thorac Surg·2009
8-other
Total number of resected lymph nodes predicts survival in esophageal cancer.
PMID 18650631·Ann Surg·2008
8-other
Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
PMID 18376186·Ann Surg·2008
8-other
Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer.
PMID 15930356·Clin Cancer Res·2005
8-other
Bronchioloalveolar carcinoma and ground glass opacities.
PMID 16189869·Ann Thorac Surg·2005
8-other
En-bloc esophagectomy--the three-field dissection.
PMID 15927655·Surg Clin North Am·2005
6-review
Bronchioloalveolar carcinoma in small pulmonary nodules: clinical relevance.
PMID 16087079·Semin Thorac Cardiovasc Surg·2005
8-other
COX-2: a target for prevention and treatment of esophageal cancer.
PMID 15013721·J Surg Res·2004
6-review
COX-2 inhibition in upper aerodigestive tract tumors.
PMID 15252927·Semin Oncol·2004
6-review
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.
PMID 12860939·J Clin Oncol·2003
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
525 E 68TH ST # M-404
NEW YORK, NY 10065

Quick Facts

NPI
1700973898
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
49
Publications
20

Are you this provider?

Claim Your Profile